Tech Company Financing Transactions
Anivive Lifesciences Funding Round
On 1/27/2025, Anivive Lifesciences raised $20 million in investment from Leonid Capital Partners.
Transaction Overview
Company Name
Announced On
1/27/2025
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Leonid Capital Partners (Chris Lay)
Proceeds Purpose
The investment will help Anivive bolster its research programs, expand its manufacturing capabilities, and drive commercialization of its canine vaccine for Valley fever, the first-ever antifungal vaccine.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
3777 Worsham Ave 200
Long Beach, CA 90808
USA
Long Beach, CA 90808
USA
Phone
Undisclosed
Website
Email Address
Overview
We believe pets deserve more therapeutics developed and approved specifically for them. Anivive Lifesciences, Inc. is a next generation animal health company. We combine artificial intelligence software, biotech, and veterinary medicine to serve the unmet medical needs of pets with a diverse pipeline of innovative products to treat cancers, infectious diseases, and endocrine conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dylan Balsz
Chief Financial Officer
Cheryl Collett
Chief Medical Officer
Dave Bruyette
Chief Technical Officer
Cody Arbuckle
Vice President
Niki Waldron
VP - Bus. Development
Chad Dodd
VP - Bus. Development
Edward Robb
VP - Regulatory Affairs
Steve Sutherland
Browse more venture capital transactions:
Prev: 1/27/2025: Sightline Climate venture capital transaction
Next: 1/27/2025: MarkeTeam.ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs